Drawing for CURIA

USPTO serial 88880211

CURIA

Reviewed by CopyMark Law Group

Reg. 6909290Status 700Registered
Filing date
Status date
Registration date
Nov 29, 2022
Examiner
SALCIDO, JOHN CHARLES
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CURIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Geza C. Ziegler, Jr.

Geza C. Ziegler, Jr. ZIEGLER IP LAW GROUP, LLC3135 Easton TpkeFAIRFIELD, CT 06825UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for use in database management relating to the field of science and medicine, the database relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionals; Computer software namely, downloadable computer software for use in database management relating to the field of science and medicine, in particular, the database relating to medicines, clinical trials, medical and healthcare professionals; Computer software relating to the medical field namely, downloadable computer software for use in database management relating to the field of science and medicine, the database relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionals; Downloadable mobile applications for providing information related to the field of science and medicine, the information relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionals, scheduling medical appointments and online consultation with medical and healthcare professionals; Software applications for use with mobile devices, namely, downloadable computer software for use in database management relating to the field of science and medicine, the database relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionals; Downloadable computer software for creating searchable databases of information and data; Downloadable computer software for authorising access to data bases; Downloadable computer application software for providing information related to life sciences and pharma domain using proprietary and non-proprietary databases; Downloadable mobile applications for providing information related to life sciences and pharma domain using proprietary and non-proprietary databases; Downloadable mobile applications for the management of information; Downloadable mobile applications for the transmission of informationACTIVE—
042Medical research services; Medical and pharmacological research services; Research on the subject of pharmaceuticals; Computer programming in the medical field; Scientific investigations for medical purposes; Scientific research for medical purposes in the area of cancerous diseases; Research and development in the pharmaceutical and biotechnology fields; Providing scientific information in the field of medical disorders and their treatment; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Computer software relating to the medical field, namely, providing on-line non-downloadable software for use in database management relating to the field of science and medicine, the database relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionals; Software applications for use with mobile devices, namely, providing temporary use of a web-based software application for use in database management relating to the field of science and medicine, the database relating to medicines, pharmaceutical and clinical trials, medical and healthcare professionalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 29, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 29, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 13, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 13, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 24, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 9, 2022FIXDELECTRONIC RECORD REVIEW COMPLETE—
Aug 5, 2022ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Aug 1, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 26, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 26, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 26, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 18, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2022DOCKASSIGNED TO EXAMINER—
Mar 15, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 15, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 15, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 6, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 6, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Jan 6, 2022CNSLSUSPENSION LETTER WRITTEN—
Nov 26, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 26, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 26, 2021ALIEASSIGNED TO LIE—
Nov 22, 2021ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 26, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 21, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 21, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Jan 21, 2021CNSLSUSPENSION LETTER WRITTEN—
Jan 20, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 20, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 20, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 20, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 20, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 20, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 14, 2020DOCKASSIGNED TO EXAMINER—
Apr 30, 2020MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 29, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 24, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance